Neuromuscular Disease News and Research

RSS
Invasive strategy benefits patients with myotonic dystrophy type 1 neuromuscular disorder

Invasive strategy benefits patients with myotonic dystrophy type 1 neuromuscular disorder

TACT believes that Halo's HT-100 may effectively treat DMD

TACT believes that Halo's HT-100 may effectively treat DMD

Ultragenyx completes UX001 Phase 1 study on hereditary inclusion body myopathy

Ultragenyx completes UX001 Phase 1 study on hereditary inclusion body myopathy

Prosensa secures €23M in new equity financing

Prosensa secures €23M in new equity financing

Four Loyola anesthesiologists have written chapters for Manual of Clinical Anesthesiology

Four Loyola anesthesiologists have written chapters for Manual of Clinical Anesthesiology

Immunosuppressant combination improves survival of human spinal stem cells in ALS rat model

Immunosuppressant combination improves survival of human spinal stem cells in ALS rat model

People with myotonic muscular dystrophy more likely to develop cancer

People with myotonic muscular dystrophy more likely to develop cancer

ACGME approves Cedars-Sinai's neurology residency training program

ACGME approves Cedars-Sinai's neurology residency training program

Health supplement hope for child muscle disease

Health supplement hope for child muscle disease

Cancer cells maintain rapid proliferation due to PK-M2 enzyme

Cancer cells maintain rapid proliferation due to PK-M2 enzyme

People with Parkinson's can benefit from computer-based physical therapy games

People with Parkinson's can benefit from computer-based physical therapy games

FARA announces 2011 Ataxian Athlete Initiative grant recipients

FARA announces 2011 Ataxian Athlete Initiative grant recipients

FDA approves NeuRx Diaphragm Pacing System to treat ALS

FDA approves NeuRx Diaphragm Pacing System to treat ALS

Researchers identify common genetic mutation for ALS, frontotemporal dementia

Researchers identify common genetic mutation for ALS, frontotemporal dementia

Researchers’ discovery may revolutionize treatment of Lou Gehrig’s disease

Researchers’ discovery may revolutionize treatment of Lou Gehrig’s disease

Encouraging results from Alexion's eculizumab Phase 2 study on generalized myasthenia gravis

Encouraging results from Alexion's eculizumab Phase 2 study on generalized myasthenia gravis

Walgreens, MDA team up to offer free seasonal flu shots

Walgreens, MDA team up to offer free seasonal flu shots

WSU researcher receives $418,000 NINDS grant to study spinal muscular atrophy

WSU researcher receives $418,000 NINDS grant to study spinal muscular atrophy

NIH/NINDS awards AMRI to develop pre-clinical drug candidate for spinal muscular atrophy

NIH/NINDS awards AMRI to develop pre-clinical drug candidate for spinal muscular atrophy

New application for understanding peripheral nervous system

New application for understanding peripheral nervous system